Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 32 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7601718

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  2. US 7598245

    Aminotriazole compounds useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  3. US 7598412

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  4. US 7598277

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted

  5. US 7592368

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted

  6. US 7592340

    Quinoxalines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted

  7. US 7589214

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted

  8. US 7582641

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted

  9. US 7569591

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  10. US 7569604

    Heterocyclic derivatives for modulation of calcium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  11. US 7563795

    Phenyl-piperazine derivatives as modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted

  12. US 7557106

    Substituted pyrimidines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  13. US 7553852

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  14. US 7553855

    Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  15. US 7547794

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  16. US 7531570

    Treatment of diseases using ICE inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  17. US 7531523

    Sodium channel protein type III alpha-subunit splice variant

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  18. US 7531556

    Compositions useful as inhibitors of rock and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  19. US 7531536

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2009 · Expires May 7, 2029

    granted

  20. US 7527952

    Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA)

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  21. US 7528138

    Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  22. US 7528142

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  23. US 7517987

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  24. US 7514448

    Azaindoles useful as inhibitors of rock and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.